| Literature DB >> 34715021 |
Karl N Miller1, Stella G Victorelli2, Hanna Salmonowicz3, Nirmalya Dasgupta1, Tianhui Liu1, João F Passos4, Peter D Adams5.
Abstract
Endogenous cytoplasmic DNA (cytoDNA) species are emerging as key mediators of inflammation in diverse physiological and pathological contexts. Although the role of endogenous cytoDNA in innate immune activation is well established, the cytoDNA species themselves are often poorly characterized and difficult to distinguish, and their mechanisms of formation, scope of function and contribution to disease are incompletely understood. Here, we summarize current knowledge in this rapidly progressing field with emphases on similarities and differences between distinct cytoDNAs, their underlying molecular mechanisms of formation and function, interactions between cytoDNA pathways, and therapeutic opportunities in the treatment of age-associated diseases.Entities:
Keywords: aging; cancer; cytoplasmic DNA; cytoplasmic chromatin fragment; micronucleus; mitochondrial DNA; retrotransposon; senescence
Mesh:
Substances:
Year: 2021 PMID: 34715021 PMCID: PMC8627867 DOI: 10.1016/j.cell.2021.09.034
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582